| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerating the establishment of management systems for compassionate use in China
|
Wang, Shuhang
|
|
|
29 |
7 |
p.
|
artikel
|
| 2 |
All-in-one nanotheranostic platform based on tumor microenvironment: new strategies in multimodal imaging and therapeutic protocol
|
Li, Yanchen
|
|
|
29 |
7 |
p.
|
artikel
|
| 3 |
An exploration of alternative therapeutic targets for aortic disease in Marfan syndrome
|
Van Den Heuvel, Lotte J.F.
|
|
|
29 |
7 |
p.
|
artikel
|
| 4 |
A review on the recent advances of interaction studies of anticancer metal-based drugs with therapeutic targets, DNA and RNAs
|
Khan, Huzaifa Yasir
|
|
|
29 |
7 |
p.
|
artikel
|
| 5 |
Best practices for machine learning in antibody discovery and development
|
Wossnig, Leonard
|
|
|
29 |
7 |
p.
|
artikel
|
| 6 |
Coupling of surface plasmon resonance and mass spectrometry for molecular interaction studies in drug discovery
|
Zhao, Yuandi
|
|
|
29 |
7 |
p.
|
artikel
|
| 7 |
Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunity
|
Callenbach, Marcelien H.E.
|
|
|
29 |
7 |
p.
|
artikel
|
| 8 |
Current status of drugs targeting PDGF/PDGFR
|
Ai, Jing-Yan
|
|
|
29 |
7 |
p.
|
artikel
|
| 9 |
Design of greener drugs: aligning parameters in pharmaceutical R&D and drivers for environmental impact
|
Vidaurre, Rodrigo
|
|
|
29 |
7 |
p.
|
artikel
|
| 10 |
Enzyme-responsive liposomes for controlled drug release
|
Wei, Yan
|
|
|
29 |
7 |
p.
|
artikel
|
| 11 |
Exosome-mediated PROTAC delivery for treatment of RNA viral infections and zoonosis
|
Mukerjee, Nobendu
|
|
|
29 |
7 |
p.
|
artikel
|
| 12 |
Geometric deep learning methods and applications in 3D structure-based drug design
|
Bai, Qifeng
|
|
|
29 |
7 |
p.
|
artikel
|
| 13 |
Harnessing the role of microneedles as sensors: current status and future perspectives
|
Ravindra Babu, Molakpogu
|
|
|
29 |
7 |
p.
|
artikel
|
| 14 |
Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned
|
Hogervorst, Milou A.
|
|
|
29 |
7 |
p.
|
artikel
|
| 15 |
Impact of the diseased lung microenvironment on the in vivo fate of inhaled particles
|
Gai, Jiayi
|
|
|
29 |
7 |
p.
|
artikel
|
| 16 |
Mycobacteriophages: therapeutic approach for mycobacterial infections
|
Raman, Sunil Kumar
|
|
|
29 |
7 |
p.
|
artikel
|
| 17 |
Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy
|
Dai, Jingyuan
|
|
|
29 |
7 |
p.
|
artikel
|
| 18 |
Peptide spiders are emerging as novel therapeutic interventions for nucleic acid delivery
|
Rahman, Mahfoozur
|
|
|
29 |
7 |
p.
|
artikel
|
| 19 |
Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents
|
Pereira, Márcia
|
|
|
29 |
7 |
p.
|
artikel
|
| 20 |
Role of transient receptor potential channels in the regulation of vascular tone
|
Hu, Xiang-Qun
|
|
|
29 |
7 |
p.
|
artikel
|
| 21 |
Small molecular inhibitors: Therapeutic strategies for pancreatic cancer
|
Golivi, Yuvasri
|
|
|
29 |
7 |
p.
|
artikel
|
| 22 |
Targeting furin, a cellular proprotein convertase, for COVID-19 prevention and therapeutics
|
Jiang, Xia
|
|
|
29 |
7 |
p.
|
artikel
|
| 23 |
The impact of E3 ligase choice on PROTAC effectiveness in protein kinase degradation
|
Sobierajski, Tomasz
|
|
|
29 |
7 |
p.
|
artikel
|
| 24 |
The importance of a go-to-market strategy in the commercialisation of cellular immunotherapies
|
Piñel-Neparidze, Cristina
|
|
|
29 |
7 |
p.
|
artikel
|
| 25 |
The role of RIPK1 in chronic obstructive pulmonary disease
|
Tiwari, Aman
|
|
|
29 |
7 |
p.
|
artikel
|
| 26 |
THPdb2: compilation of FDA approved therapeutic peptides and proteins
|
Jain, Shipra
|
|
|
29 |
7 |
p.
|
artikel
|
| 27 |
Toward structure–multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective
|
López-López, Edgar
|
|
|
29 |
7 |
p.
|
artikel
|
| 28 |
Unlocking the potential of flavonoid-based co-crystal and co-amorphous systems
|
Rode, Khushi
|
|
|
29 |
7 |
p.
|
artikel
|
| 29 |
VISTA: A Novel Checkpoint for Cancer Immunotherapy
|
Gao, Yu
|
|
|
29 |
7 |
p.
|
artikel
|
Tijdschrift beschrijving